Literature DB >> 19232965

A retrospective study of radiofrequency thermal lesioning for the treatment of neuritis of the medial calcaneal nerve and its terminal branches in chronic heel pain.

Joseph A Cione1, John Cozzarelli, Christopher Jay Mullin.   

Abstract

UNLABELLED: We undertook a retrospective analysis of 75 consecutive patients with recalcitrant plantar heel pain caused by calcaneal neuritis, all who were treated with radiofrequency thermal lesioning (RTL). The median age of the cohort was 55 (range 24 to 83) years, 25 (33.3%) of the patients were male, 50 (66.7%) of the patients were female, and 15 (20%) of the patients were treated for bilateral heel pain caused by medial calcaneal neuritis. The median preoperative VAS score was 9 (range 2 to 10), whereas the median long-term postoperative VAS score was 1 (range 0 to 8), and this difference was highly statistically significant (P < .0001). Five (6.7%) of the patients experienced recurrent heel pain, over a median follow-up duration of 18 (range 12 to 36) months. Overall, 93.3% of the patients experienced satisfactory pain relief with radiofrequency lesioning for the treatment of recalcitrant plantar heel pain caused by medial calcaneal neuritis. LEVEL OF CLINICAL EVIDENCE: 2.

Entities:  

Mesh:

Year:  2009        PMID: 19232965     DOI: 10.1053/j.jfas.2008.11.007

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  3 in total

1.  Ultrasound-guided treatment of Morton's neuroma.

Authors:  Michail E Klontzas; Emmanouil Koltsakis; George A Kakkos; Apostolos H Karantanas
Journal:  J Ultrason       Date:  2021-06-18

2.  Combination of diagnostic medial calcaneal nerve block followed by pulsed radiofrequency for plantar fascitis pain: A new modality.

Authors:  Deepak Thapa; Vanita Ahuja
Journal:  Indian J Anaesth       Date:  2014-03

3.  Efficacy of acupuncture versus sham acupuncture or waitlist control for patients with chronic plantar fasciitis: study protocol for a two-centre randomised controlled trial.

Authors:  Weiming Wang; Sixing Liu; Yan Liu; Zhiwei Zang; Weina Zhang; Liang Li; Zhishun Liu
Journal:  BMJ Open       Date:  2020-09-25       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.